While the standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two
doses administered 3 weeks apart, some public health authorities are spacing these doses, …

SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic, infecting
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …

With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines,
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS-…

In the absence of effective vaccines and with limited therapeutic options, convalescent plasma
is being collected across the globe for potential transfusion to coronavirus disease 2019 (…

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) mediates viral
entry into cells and is critical for vaccine development against coronavirus disease 2019 (…

The standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses
administered three weeks apart. However, some public health authorities spaced these …

Background Where P. vivax and P. falciparum occur in the same population, the peak burden
of P. vivax infection and illness is often concentrated in younger age groups. Experiences …

Characterization of the humoral response to SARS-CoV-2, the etiological agent of COVID-19,
is essential to help control the infection. The neutralization activity of plasma from patients …

Continuous emergence of SARS-CoV-2 variants of concern (VOCs) is fueling the COVID-19
pandemic. Omicron (B.1.1.529) rapidly spread worldwide. The large number of mutations in …

Despite advances in COVID-19 management, identifying patients evolving toward death
remains challenging. To identify early predictors of mortality within 60 days of symptom onset (…